Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$0.13 - $76.84 $20,633 - $12.2 Million
158,721 New
158,721 $11.3 Million
Q2 2022

Aug 15, 2022

SELL
$72.62 - $79.98 $14.1 Million - $15.6 Million
-194,684 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$61.48 - $73.72 $12 Million - $14.4 Million
194,684 New
194,684 $14.2 Million
Q4 2021

Feb 14, 2022

SELL
$53.63 - $62.52 $11.4 Million - $13.2 Million
-211,821 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$59.17 - $69.31 $6.55 Million - $7.68 Million
110,740 Added 109.56%
211,821 $12.5 Million
Q2 2021

Aug 16, 2021

SELL
$61.91 - $67.42 $8.22 Million - $8.95 Million
-132,817 Reduced 56.78%
101,081 $6.75 Million
Q1 2021

May 17, 2021

SELL
$59.34 - $66.74 $603,369 - $678,612
-10,168 Reduced 4.17%
233,898 $14.8 Million
Q4 2020

Feb 16, 2021

SELL
$57.74 - $65.43 $8.44 Million - $9.56 Million
-146,090 Reduced 37.44%
244,066 $15.1 Million
Q3 2020

Nov 16, 2020

BUY
$57.43 - $63.64 $20.3 Million - $22.5 Million
354,047 Added 980.5%
390,156 $23.5 Million
Q2 2020

Aug 14, 2020

SELL
$54.82 - $64.09 $5.53 Million - $6.46 Million
-100,816 Reduced 73.63%
36,109 $2.12 Million
Q1 2020

May 15, 2020

SELL
$46.4 - $67.43 $12.3 Million - $17.8 Million
-264,509 Reduced 65.89%
136,925 $7.63 Million
Q4 2019

Feb 14, 2020

BUY
$49.21 - $64.19 $5.39 Million - $7.03 Million
109,509 Added 37.51%
401,434 $25.8 Million
Q3 2019

Nov 14, 2019

BUY
$42.77 - $50.71 $8.79 Million - $10.4 Million
205,628 Added 238.28%
291,925 $14.8 Million
Q2 2019

Aug 14, 2019

SELL
$44.62 - $49.34 $9.15 Million - $10.1 Million
-204,984 Reduced 70.37%
86,297 $3.91 Million
Q1 2019

May 15, 2019

BUY
$45.12 - $53.8 $10.9 Million - $13 Million
241,944 Added 490.39%
291,281 $13.9 Million
Q4 2018

Feb 14, 2019

SELL
$48.76 - $63.23 $1.4 Million - $1.81 Million
-28,634 Reduced 36.72%
49,337 $2.57 Million
Q3 2018

Nov 14, 2018

BUY
$55.19 - $62.25 $4.3 Million - $4.85 Million
77,971 New
77,971 $4.84 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $113B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Endurant Capital Management LP Portfolio

Follow Endurant Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Endurant Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Endurant Capital Management LP with notifications on news.